Compass Therapeutics, Inc.
New Filing
CIK: 0001738021·Other·DELAWARE·Filed: Jul 1, 2020
Total Offering
$195,276,780
Amount Sold
$195,276,780
Investors
114
First Sale
Jun 17, 2020
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2018
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Julie Sunderland | Related Person |
| Carl L. Gordon | Related Person |
| THOMAS J SCHUETZ | Related Person |
| Philip Ferneau | Related Person |
| Stephen P. Squinto | Related Person |
| VERED BISKER-LEIB | Related Person |
Company
SEC Filing
0001802806-20-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free